Changes in Growth-Associated Protein 43 and Tensor-Based Morphometry Indices in Mild Cognitive Impairment

Changes in Growth-Associated Protein 43 and Tensor-Based Morphometric Indicators in Mild Cognitive Impairment Research Background Alzheimer’s disease (AD) is a globally prevalent neurodegenerative disease whose incidence is expected to increase significantly in the coming years (Esquerda-Canals et al., 2017). The disease primarily manifests as defe...

Comprehensive Assessment of TDP-43 Neuropathology Data in the National Alzheimer’s Coordinating Center Database

Research Report Titled “Comprehensive Evaluation of TDP-43 Neuropathology Data in the National Alzheimer’s Coordinating Center Database” Research Background TDP-43 proteinopathy is a significant neuropathological feature in frontotemporal lobar degeneration (FTLD-TDP), amyotrophic lateral sclerosis (ALS-TDP), and age-related limbic TDP-43 encephalo...

Alteration of Gene Expression and Protein Solubility of the PI5-Phosphatase SHIP2 are Correlated with Alzheimer’s Disease Pathology Progression

Changes in Gene Expression and Protein Insolubility in Alzheimer’s Disease Progression Background Introduction As the most common type of dementia, Alzheimer’s Disease (AD) is well-known for its two main neuropathological features: amyloid plaques and neurofibrillary tangles (NFTs). Amyloid plaques consist of β-amyloid (Aβ) peptide segments generat...

Characterisation of Premature Cell Senescence in Alzheimer’s Disease Using Single Nuclear Transcriptomics

Characterisation of Premature Cell Senescence in Alzheimer’s Disease Using Single Nuclear Transcriptomics

Characteristics of Premature Cellular Senescence in Alzheimer’s Disease: Application of Single-Nucleus Transcriptomics Research Background and Objectives Alzheimer’s disease (AD) is the most common type of dementia in the elderly, characterized by extracellular deposition of β-amyloid protein and intracellular neurofibrillary tangles. Other patholo...

Functional Connectivity Changes in Mild Cognitive Impairment: A Meta-Analysis of M/EEG Studies

Changes in Functional Connectivity in Mild Cognitive Impairment: A Meta-Analysis of M/EEG Studies Background and Objectives Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by memory loss and cognitive impairment. AD is the leading cause of cognitive disorders in the elderly, accounting for approximately 60% to 80% of global c...

Chronic Evoked Seizures in Young Pre-symptomatic APP/PS1 Mice Induce Serotonin Changes and Accelerate Onset of Alzheimer’s Disease-Related Neuropathology

APP/PS1 Mouse Study Reveals Link Between Chronic Induced Epilepsy and Alzheimer’s Disease Background Alzheimer’s Disease (AD) is the most common type of dementia globally, affecting over 55 million people. The typical pathological feature of AD is the deposition of amyloid-β (Aβ) in the brain. Although Aβ deposition and the mechanisms it triggers p...

APOE4 Homozygosity Represents a Distinct Genetic Form of Alzheimer’s Disease

APOE4 Homozygotes Represent a Unique Genotypic Subset of Alzheimer’s Disease Introduction Alzheimer’s disease (AD) is one of the neurodegenerative diseases that modern medicine has yet to conquer, usually with a complex genetic background. While mutations in three genes (APP, PSEN1, and PSEN2) lead to early-onset autosomal dominant Alzheimer’s dise...